Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service
COVID-19
1 other identifier
observational
45
1 country
1
Brief Summary
comparison of general characteristics of patients diagnosed COVID-19 positive followed In service
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2021
CompletedFirst Posted
Study publicly available on registry
October 25, 2021
CompletedStudy Start
First participant enrolled
May 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2022
CompletedMay 6, 2022
May 1, 2022
2 months
October 22, 2021
May 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Number of Participants
Number of Participants diagnosed of polymerase chain reaction assay Positive COVID-19 followed İn service
Two months
Number of vaccinated participants
Vaccinated patients who were followed up in the service due to COVID-19
Two months
Number of non-vaccinated Participants
non-vaccinated patients who were followed up in the service due to COVID-19
Two months
rate of non-vaccinated -vaccinated Participants
rate of non-vaccinated- vaccinated Participants who were followed up in the service due to COVID-19
Two months
rate of covid symptoms
rate of covid common symptoms (cough, fever, shortness of breath ,sore throat ) in vaccinated and unvaccinated patients
Two months
rate of inflammatory parameters
rate of lymphocyte and albumin levels , C-reactive protein (CRP), D-dimer, Ferritin, lactate dehydrogenase(LDH), neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR) and C-reactive protein albumin ratio (CAR) levels in vaccinated and unvaccinated patients
Two months
Study Arms (1)
covid pregnancy
Pregnant patients with positive polymerase chain reaction assay COVID-19 test results, who were followed up and treated in the pandemic service of Başakşehir Çam and Sakura City Hospital.
Eligibility Criteria
Pregnant patients with positive COVID-19 test results, who were followed up and treated in the pandemic service of Çam and Sakura City Hospital.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Obstetrics and Gynecology, Maternal-Fetal Medicine Unit, Başakşehir City Hospital, Hamidiye School of Medicine, University of Health Sciences,
Başaksehir, Istanbul, 34480, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ozge Ozdemir
Saglik Bilimleri Universitesi
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
October 22, 2021
First Posted
October 25, 2021
Study Start
May 5, 2022
Primary Completion
July 15, 2022
Study Completion
July 15, 2022
Last Updated
May 6, 2022
Record last verified: 2022-05